NovoCure Ltd. appointed David Hung and Sherilyn McCoy to its board.
Hung is the former president and CEO of Medivation Inc., a privately held biopharmaceutical company. McCoy is the former CEO of Avon Products Inc. which sells beauty, household and personal care items.
"Both will provide important insights and guidance as we grow our glioblastoma business and advance our proprietary cancer therapy to commercialize indications beyond GBM," said Bill Doyle, executive chairman of NovoCure.
Concurrently, NovoCure said Gert Lennart Perlhagen is retiring as a board member after 15 years of service.
St. Helier, Jersey-based NovoCure is developing treatments for solid tumors.
